APA (7th ed.) Citation

Xiujing He, Jing Yu, & Hubing Shi. (2021). Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Xiujing He, Jing Yu, and Hubing Shi. Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Xiujing He, et al. Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A., 2021.